The estimated Net Worth of Birgit Girshick is at least $17 Milión dollars as of 10 January 2024. Ms. Girshick owns over 5,916 units of Charles River Laboratories International stock worth over $9,750,160 and over the last 7 years she sold CRL stock worth over $4,230,765. In addition, she makes $2,988,000 as Corporate Executive Vice President, Global Discovery and Safety Assessment a Biologics and Avian at Charles River Laboratories International.
Birgit has made over 16 trades of the Charles River Laboratories International stock since 2018, according to the Form 4 filled with the SEC. Most recently she exercised 5,916 units of CRL stock worth $1,273,064 on 10 January 2024.
The largest trade she's ever made was exercising 19,310 units of Charles River Laboratories International stock on 5 April 2021 worth over $2,171,603. On average, Birgit trades about 1,653 units every 52 days since 2018. As of 10 January 2024 she still owns at least 50,365 units of Charles River Laboratories International stock.
You can see the complete history of Ms. Girshick stock trades at the bottom of the page.
Birgit Girshick serves as Corporate Executive Vice President, Global Discovery and Safety Assessment, Biologics and Avian of the Company. She joined us in 1989 and has held positions of increasing responsibility in our RMS Germany and RMS Avian Vaccine businesses. In 2004, Ms. Girshick was promoted to General Manager of the RMS Avian Vaccine Services business. She was named Executive Director, RMS Process Improvement in 2009, and Corporate Vice President, Global Biopharmaceutical Services in 2010. In 2013, Ms. Girshick was promoted to Corporate Senior Vice President, Research Models and Biologics Testing Solutions. In 2016, Ms. Girshick was tasked with leading the integration of WIL Research into our Safety Assessment business. Also in 2016, Ms. Girshick assumed the role of Corporate Senior Vice President, Global Discovery Services. In February 2018, Ms. Girshick was appointed Corporate Executive Vice President, Discovery and Safety Assessment.
As the Corporate Executive Vice President, Global Discovery and Safety Assessment a Biologics and Avian of Charles River Laboratories International, the total compensation of Birgit Girshick at Charles River Laboratories International is $2,988,000. There are 4 executives at Charles River Laboratories International getting paid more, with James Foster having the highest compensation of $17,722,100.
Birgit Girshick is 50, she's been the Corporate Executive Vice President, Global Discovery and Safety Assessment a Biologics and Avian of Charles River Laboratories International since 2018. There are 18 older and 3 younger executives at Charles River Laboratories International. The oldest executive at Charles River Laboratories International Inc. is Stephen Chubb, 76, who is the Independent Director.
Over the last 21 years, insiders at Charles River Laboratories International have traded over $220,588,205 worth of Charles River Laboratories International stock and bought 18,392 units worth $3,841,397 . The most active insiders traders include James C Foster, Richard F Wallman a David P Johst. On average, Charles River Laboratories International executives and independent directors trade stock every 14 days with the average trade being worth of $2,223,188. The most recent stock trade was executed by Joseph W La Plume on 8 August 2024, trading 1,780 units of CRL stock currently worth $354,861.
charles river provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. #drugdiscovery #biotech #biotechnology #pharmaceuticals #cro
Charles River Laboratories International executives and other stock owners filed with the SEC include: